Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10233235
Modulating the alternative complement pathway
granted -
US 10233170
2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use
granted -
US 10233450
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 10233463
Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling
granted -
US 10231988
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
granted -
US 10231998
Method for chemoselection
granted -
US 10233448
Modified double-stranded RNA agents
granted -
US 10231947
Isochroman compounds and methods of use thereof
granted -
US 10233429
Hand, foot, and mouth vaccines and methods of manufacture and use thereof
granted -
US 10232042
Conjugates of an anti-TNF-alpha antibody
granted -
US 10232035
Conditionally replication deficient herpes virus and use thereof in vaccines
granted -
US 10232041
Combination of lenalidomide and polypeptide construct, and uses thereof
granted -
US 10233142
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
granted -
CA 3075215
INHIBITEUR DE L'HISTONE DESACETYLASE EN ASSOCIATION AVEC UN MODULATEUR DE POINT DE CONTROLE IMMUNITAIRE POUR LA CANCEROTHERAPIE
granted -
WO 2019048531
NANOPARTICULES MODIFIÉES PAR L'ALBUMINE PORTANT UN LIGAND DE CIBLAGE
granted -
US 2019076525
THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
granted -
US 10226520
Compositions and methods for enterohemorrhagic Escherichia coli (EHEC) vaccination
granted -
US 10227362
Anti-pulmonary tuberculosis nitroimidazole derivative
granted -
US 10226426
Suspension containing nano-cocrystal and manufacturing method
granted -
US 10227611
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10226487
Derivation and self-renewal of lsl1+ cells and uses thereof
granted -
US 10226472
Methods for the treatment of breast cancer
granted -
US 10227312
Glucosylceramide synthase inhibitors for the treatment of diseases
granted -
US 10227567
Isolation and use of solid tumor stem cells
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.